NEW YORK–(BUSINESS WIRE)—- $BMEZ–BlackRock Health Sciences Term Trust (the “Fund”) announced today the final results of its tender offer (“Tender Offer”) for up to 5% of its outstanding common shares (the “Shares”). The Tender Offer, which expired at 5:00 p.m. Eastern time on November 18, 2026, was oversubscribed. Therefore, in accordance with the terms and conditions of the Tender Offer, the Fund will purchase Shares from all tendering shareholders on a pro rata basis, after disregarding fractions,